Vaccibody As
Records under this name other than patents Vaccibody As holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,932,603 | Modified antibody Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,590,195 | Homodimeric protein constructs Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,479,605 | Homodimeric protein constructs Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,901,635 | Vaccines against HPV Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,358,989 | HLA binding vaccine moieties and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,059,459 | Therapeutic Anticancer Neoepitope Vaccine Formerly held In force · High confidence | In force | High confidence | |
| US 11,780,924 | HLA binding vaccine moieties and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,462,898 | Method for selecting neoepitopes Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,169,322 | Modified antibody Formerly held Term ended Term ended Jun 27, 2025 · USPTO record | Term ended | Term ended Jun 27, 2025 | USPTO record |
| US 9,796,787 | Modified antibody Formerly held Term ended Ended no later than Feb 25, 2024 · USPTO record | Term ended | Ended no later than Feb 25, 2024 | USPTO record |